Abstract
In the current review, we discuss the role of NF-κB and JAK/STAT signaling pathways and their small molecule regulators in the therapy of inflammatory diseases. Considering potential harmful effects directly assigned to the COX-2 inhibition, novel therapeutically-relevant biological targets such as NF-κB and JAK/STAT signaling pathways have received a growing attention. Here we summarize recent progress in the identification and development of novel, clinically approved or evaluated small molecule regulators of these signaling cascades as promising anti-inflammatory therapeutics. In addition, we illustrate key structural modifications and bioisosteric transformations among these inhibitors to provide a helpful basis for further development of novel small molecule anti-inflammatory agents.
Keywords: NF-κB, JAK/STAT, signalling, inhibitors, anti-inflammatory, therapy, Chronic inflammation, rheumatoid arthritis, ischaemic heart disease, atherosclerosis, cancer, fibrosis, Hayfever, Alzheimer's diseases, MAPKs, STAT, NSAIDs, Valdecoxib, leukemia, inflammatory bowel disease, arthritis, sepsis, asthma, multiple sclerosis, colitis, diabetic neuropathy, AIDS, GPCR, TNFR, NEMO, oxycodone/ibuprofen, Oxycodone, Bortezomib, RS-411, Fumaderm, Gabexate, MK-231, Silibinin, ST-1482, RK-0202, Salazosulfapyridine, Curaxin CBLC-102, NGX-3781, Hydrocodone, NSC-49171, Pseudoephedrine, T-614, Curcumin, MPC-7869, Dimethyl fumarate, Famotidine, Fluasterone, Tepoxalin, E-3330, EGCG, Declopramide, Resveratrol, Tranexamic acid, RTA-402, Orazipone, RTA-401, ALS-357, IMD-0354, SIM-688, ENMD-1198, Parthenolide, Cepharanthine, Taxifolin, SC-514, TPCA-1, BMS-345541, ML120B, HUVECs, RHEC, HMGB1, lung lavage, neutrophil influx, lung edema, SOCS, PIAS, Lestaurtinib, MHCII, HWA-486, CP-690550, MK-0457, TG-101348, LS-104, SKI-606, Atiprimod, ABT-869, mixed lymphocyte reaction, mycophenolate mofetil
Mini-Reviews in Medicinal Chemistry
Title: Small Molecule Inhibitors of NF-κB and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics
Volume: 11 Issue: 1
Author(s): Y. A. Ivanenkov, K. V. Balakin and Y. Lavrovsky
Affiliation:
Keywords: NF-κB, JAK/STAT, signalling, inhibitors, anti-inflammatory, therapy, Chronic inflammation, rheumatoid arthritis, ischaemic heart disease, atherosclerosis, cancer, fibrosis, Hayfever, Alzheimer's diseases, MAPKs, STAT, NSAIDs, Valdecoxib, leukemia, inflammatory bowel disease, arthritis, sepsis, asthma, multiple sclerosis, colitis, diabetic neuropathy, AIDS, GPCR, TNFR, NEMO, oxycodone/ibuprofen, Oxycodone, Bortezomib, RS-411, Fumaderm, Gabexate, MK-231, Silibinin, ST-1482, RK-0202, Salazosulfapyridine, Curaxin CBLC-102, NGX-3781, Hydrocodone, NSC-49171, Pseudoephedrine, T-614, Curcumin, MPC-7869, Dimethyl fumarate, Famotidine, Fluasterone, Tepoxalin, E-3330, EGCG, Declopramide, Resveratrol, Tranexamic acid, RTA-402, Orazipone, RTA-401, ALS-357, IMD-0354, SIM-688, ENMD-1198, Parthenolide, Cepharanthine, Taxifolin, SC-514, TPCA-1, BMS-345541, ML120B, HUVECs, RHEC, HMGB1, lung lavage, neutrophil influx, lung edema, SOCS, PIAS, Lestaurtinib, MHCII, HWA-486, CP-690550, MK-0457, TG-101348, LS-104, SKI-606, Atiprimod, ABT-869, mixed lymphocyte reaction, mycophenolate mofetil
Abstract: In the current review, we discuss the role of NF-κB and JAK/STAT signaling pathways and their small molecule regulators in the therapy of inflammatory diseases. Considering potential harmful effects directly assigned to the COX-2 inhibition, novel therapeutically-relevant biological targets such as NF-κB and JAK/STAT signaling pathways have received a growing attention. Here we summarize recent progress in the identification and development of novel, clinically approved or evaluated small molecule regulators of these signaling cascades as promising anti-inflammatory therapeutics. In addition, we illustrate key structural modifications and bioisosteric transformations among these inhibitors to provide a helpful basis for further development of novel small molecule anti-inflammatory agents.
Export Options
About this article
Cite this article as:
A. Ivanenkov Y., V. Balakin K. and Lavrovsky Y., Small Molecule Inhibitors of NF-κB and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics, Mini-Reviews in Medicinal Chemistry 2011; 11 (1) . https://dx.doi.org/10.2174/138955711793564079
DOI https://dx.doi.org/10.2174/138955711793564079 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Almonds: A Source of Healthy Molecules or a Risk of Aflatoxins Human Exposure?
Current Nutrition & Food Science Cytotoxic and Radio-sensitizing Effects of Polyphenolic Acetates in a Human Glioma Cell Line (BMG-1)
Current Pharmaceutical Design Current Status of Hormone Replacement Therapy in Post Menopausal Women
Current Drug Therapy microRNA-133: Expression, Function and Therapeutic Potential in Muscle Diseases and Cancer
Current Drug Targets Triglycerides and Cardiovascular Risk
Current Cardiology Reviews Impact of Exercise Training on Physiological Measures of Physical Fitness in the Elderly
Current Aging Science Fragment-Based Optimization of Small Molecule CXCL12 Inhibitors for Antagonizing the CXCL12/CXCR4 Interaction
Current Topics in Medicinal Chemistry Hypoxia Inducible Factor Stabilization As a Novel Strategy to Treat Anemia
Current Medicinal Chemistry Cell Adhesion Molecules and Cadmium
Current Chemical Biology Quercetin in Attenuation of Ischemic/Reperfusion Injury: A Review
Current Molecular Pharmacology Physiology of Folic Acid in Health and Disease
Current Drug Metabolism Clinical Queries Addressed in Patients with Systemic Autoimmune Diseases. Can Cardiovascular Magnetic Resonance Give the Final Solution?
Inflammation & Allergy - Drug Targets (Discontinued) Why is the Inhibition of the Renin-Angiotensin System Effective for Preventing Cardiac Events in Patients with Coronary Risk Factors or Coronary Artery Disease?
Current Cardiology Reviews C-Reactive Protein and Hypertension: Is there A Causal Relationship?
Current Pharmaceutical Design Gene Therapy Approaches for Cardiovascular Diseases
Current Gene Therapy Editorial (Thematic Issue: Disease Control and Active and Healthy Ageing: New Paradigms of Therapeutic Strategy)
Current Pharmaceutical Design Patent Foramen Ovale, the Role of Antiplatelet Therapy Alone or Anticoagulant Therapy Alone Versus Device Closure for Cryptogenic Stroke: A Review of the Literature and Current Recommendations
Cardiovascular & Hematological Agents in Medicinal Chemistry Clinical Management of Diabetes Mellitus in the Older Adult Patient
Current Diabetes Reviews Role of PPAR-γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective
Current Drug Targets - Cardiovascular & Hematological Disorders Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology